62 related articles for article (PubMed ID: 25233965)
1. Chromosomal abnormalities in primary myelodysplastic syndrome.
Rashid A; Khurshid M; Shaikh U; Adil S
J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
[TBL] [Abstract][Full Text] [Related]
3. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
Wang W; Chen Z; Yu M; Wang H; Lou J; Xu H; Hu C; Mu Q; Tong H; Wei J; Zhou X; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):818-23. PubMed ID: 26477758
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the karyotype abnormalities and its prognostic in 298 patients with myelodysplastic syndrome].
Yan X; Wei J; Wang J; Ren Y; Zhou X; Mei C; Ye L; Xie L; Hu C; Jin J; Tong H
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):297-301. PubMed ID: 25916290
[TBL] [Abstract][Full Text] [Related]
6. Primary amenorrhoea - cytogenetic study in 40 Indian women.
Banerjee B; Dutta A; Roy S; Halder A
J Obstet Gynaecol; 2024 Dec; 44(1):2348085. PubMed ID: 38708796
[TBL] [Abstract][Full Text] [Related]
7. Complex Karyotype in Hematological Diseases: A 6-Year Single Centre Study from Pakistan.
Waheed S; Hassan J; Naz M; Maqsood S; Abid M; Shan S; Nadeem M; Shamsi TS
J Oncol; 2018; 2018():2019239. PubMed ID: 29971104
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nadal N; Auger N; Bidet A; Nguyen-Khac F
Curr Res Transl Med; 2023; 71(4):103426. PubMed ID: 38016423
[TBL] [Abstract][Full Text] [Related]
9. Rare cytogenetic abnormalities in myelodysplastic syndromes.
Bacher U; Schanz J; Braulke F; Haase D
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015034. PubMed ID: 25960862
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.
Moriwaki K; Manabe A; Taketani T; Kikuchi A; Nakahata T; Hayashi Y
Int J Hematol; 2014 Nov; 100(5):478-84. PubMed ID: 25261124
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
Wall M
Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry in the diagnosis of myelodysplastic syndromes (MDS) and the value of myeloid nuclear differentiation antigen (MNDA).
Bellos F; Kern W
Cytometry B Clin Cytom; 2014 Sep; ():. PubMed ID: 25258054
[TBL] [Abstract][Full Text] [Related]
13. Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer.
Du M; Cai Q; Sun J; Zhang M; Zhang S; Liu X; Zhang M; Zhang X
J Ovarian Res; 2024 Feb; 17(1):30. PubMed ID: 38308314
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes.
Vu MP; Ha HQ; Nguyen CN
Leuk Res Rep; 2022; 18():100343. PubMed ID: 36032421
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.
Maurya N; Mohanty P; Dhangar S; Panchal P; Jijina F; Mathan SLP; Shanmukhaiah C; Madkaikar M; Vundinti BR
Sci Rep; 2022 Apr; 12(1):5925. PubMed ID: 35396491
[TBL] [Abstract][Full Text] [Related]
16. Environmental and occupational determinants of myelodysplastic syndrome: A case-control study from Pakistan.
Anwar N; Arshad A; Fatima N; Shaheen S; Bukhari S; Shamsi T
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1580. PubMed ID: 34708590
[TBL] [Abstract][Full Text] [Related]
17. Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients.
Paridar M; Zibara K; Ahmadi SE; Khosravi A; Soleymani M; Azizi E; Ghalesardi OK
Mol Cytogenet; 2021 May; 14(1):24. PubMed ID: 33964952
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
[TBL] [Abstract][Full Text] [Related]
19. Concomitant isochromosome 17q and mutated
Xu Q; Liu C; Zhang H; Liu H; Xue M; Zhang S; Liu B
Int J Clin Exp Pathol; 2017; 10(9):9786-9792. PubMed ID: 31966863
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic features in primary myelodysplastic syndrome Egyptian patients.
Elnahass Y; Youssif L
J Adv Res; 2018 Mar; 10():77-83. PubMed ID: 30046476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]